Supply market volatility. Capacity constraints. Global
uncertainty. They’re the reality of doing business in the New
Normal that all companies must deal with. Add to this calls for
reform, regulatory uncertainty, competition from generic drugs,
shrinking R&D pipelines and declining demand for elective
procedures, and the reality becomes even more complex for
healthcare concerns. On May 25, executives from top providers,
producers, payers, and distributors will discuss these challenges
and ways in which they can collaborate to overcome them during a
Townhall Meeting at Ariba LIVE (www.aribalive.com), the premier
conference for anyone engaged in buying, selling or managing cash,
hosted by Ariba, Inc. (Nasdaq: ARBA), the leading spend management
solutions provider.
“The future of healthcare has never been more uncertain,” said
Mike Dunn, Director, Healthcare Accounts, Ariba. “From reform
proposals and expiring patents to tight budgets and fewer
resources, healthcare organizations face an unprecedented set of
challenges that will require them to think and operate in different
ways to overcome.”
During the Townhall Meeting at Ariba LIVE, leading companies
across the healthcare industry will outline their challenges and
explore ways in which they can leverage new solutions and processes
to optimize their performance and enhance the results that they
deliver.
“Change is the only thing that is certain in the New Normal,”
Dunn continued. “Business needs and customer demands can change on
a dime, and companies must be able to quickly and easily dial up
the resources they need to meet them. Ariba’s solutions are
uniquely designed to provide organizations with the support they
need as they need it to do this.”
Delivered on-demand, Ariba’s solutions give companies everything
that’s needed for agile business commerce, including:
- Market-leading SaaS technology
to optimize the complete commerce lifecycle – from source-to-settle
and market-to-receipt
- A web-based community to
efficiently discover, connect and collaborate with a global network
of trading partners
- Capabilities to augment internal
resources and skills with always-on expertise and commerce
services
Many healthcare companies are already leveraging Ariba’s
solutions to adapt to the New Normal, including: AstraZeneca,
Bristol-Myers Squibb Company, Chugai Pharmaceutical Co., Ltd.,
Genzyme Corporation, GlaxoSmithKline, Health Care Service
Corporation, Hoffmann-La Roche Inc., Janssen Pharmaceutica &
Research Foundation, Medtronic, Inc., Merck & Co., Inc.,
MetLife, Inc., Novartis AG, Pfizer Inc., Ranbaxy Laboratories
Limited, Roche Pharmaceuticals, Sanofi-Aventis, Schering-Plough
Corporation and West Penn Allegheny Health System, among others.
They join 94 of the Fortune 100 and more than 295,000 other
companies who rely on Ariba to control costs, minimize risks,
improve profits and optimize cash flow and operations.
To learn more about Ariba’s offerings and the value they can
deliver for your organization, visit www.ariba.com. For additional
details on the Ariba LIVE Healthcare Townhall, or to register for
the event, visit www.aribalive.com.
About Ariba, Inc.Ariba, Inc. is the leading provider of
on-demand spend management solutions. Our mission is to transform
the way companies of all sizes, across all industries, and
geographies operate by delivering technology, service, and network
solutions that enable them to holistically source, contract,
procure, pay, manage, and analyze their spend and supplier
relationships. Delivered on demand, our enterprise-class offerings
empower companies to achieve greater control of their spend and
drive continuous improvements in financial and supply chain
performance. More than 1,000 companies, including more than half of
the companies on the Fortune 100, use Ariba solutions to manage
their spend from sourcing and orders through invoicing and payment.
For more information, visit www.ariba.com.
Copyright © 1996 – 2010 Ariba, Inc.Ariba, the Ariba logo, Ariba
LIVE, SupplyWatch, Ariba.com, Ariba.com Network and Ariba Spend
Management. Find it. Get it. Keep it. are registered trademarks of
Ariba, Inc. Ariba Spend Management, Ariba. This is Spend
Management, Ariba Solutions Delivery, Ariba Analysis, Ariba Buyer,
Ariba Category Management, Ariba Category Procurement, Ariba
Contract Compliance, Ariba Contracts, Ariba Contract Management,
Ariba Contract Workbench, Ariba Data Enrichment, Ariba eForms,
Ariba Invoice, Ariba Payment, Ariba Sourcing, Ariba Spend
Visibility, Ariba Travel and Expense, Ariba Procure-to-Pay, Ariba
Workforce, Ariba Supplier Network, Ariba Supplier Connectivity,
Ariba Supplier Performance Management, Ariba Content Procurement,
Ariba PunchOut, Ariba QuickSource, PO-Flip, Ariba Spend Management
Knowledge Base, Ariba Ready, Ariba Supply Lines, Ariba Supply
Manager, Ariba LIVE, It’s Time for Spend Management and Supplier
Lifecycle Management are trademarks or service marks of Ariba, Inc.
All other brand or product names may be trademarks or registered
trademarks of their respective companies or organizations in the
United States and/or other countries.
Ariba Safe HarborSafe Harbor Statement under the Private
Securities Litigation Reform Act 1995: Information and
announcements in this release involve Ariba's expectations,
beliefs, hopes, plans, intentions or strategies regarding the
future and are forward-looking statements that involve risks and
uncertainties. All forward-looking statements included in this
release are based upon information available to Ariba as of the
date of the release, and we assume no obligation to update any such
forward-looking statements. These statements are not guarantees of
future performance and actual results could differ materially from
our current expectations. Factors that could cause or contribute to
Ariba's operating and financial results to differ materially from
current expectations include, but are not limited to: the impact of
the credit crises on Ariba’s results of operations and financial
condition; delays in development or shipment of new versions of
Ariba's products and services; lack of market acceptance of Ariba's
existing or future products or services; inability to continue to
develop competitive new products and services on a timely basis;
introduction of new products or services by major competitors; the
ability to attract and retain qualified employees; difficulties in
assimilating acquired companies, long and unpredictable sales
cycles and the deferrals of anticipated orders; declining economic
conditions, including the impact of a recession; inability to
control costs; changes in the company's pricing or compensation
policies; significant fluctuations in our stock price; the outcome
of and costs associated with pending or potential future regulatory
or legal proceedings; the impact of our acquisitions, including the
disruption or loss of customer, business partner, supplier or
employee relationships; and the level of costs and expenses
incurred by Ariba as a result of such transactions. Factors and
risks associated with its business, including a number of the
factors and risks described above, are discussed in Ariba's Form
10-Q filed with the SEC on February 5, 2010.
Ariba (NASDAQ:ARBA)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Ariba (NASDAQ:ARBA)
Historical Stock Chart
Von Jul 2023 bis Jul 2024